{
  "id": 5366949,
  "title": "An AI drug specialist zeroes in on rare forms of obesity",
  "url": "https://urgent.news/2026/09/03/an-ai-drug-specialist-zeroes-in-on-rare-forms-of-obesity",
  "topic": "ai",
  "section": "AI",
  "published": "2026-09-03T16:20:00.000Z",
  "source": {
    "name": "BioPharma Dive",
    "slug": "biopharma-dive",
    "url": "https://www.biopharmadive.com/news/superluminal-medicines-obesity-ai-drug-discovery-series-b/829552/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Superluminal Medicines banked $60 million in funding to support development of a drug designed to work similarly to — but potentially be more selectively than — Rhythm Pharmaceuticals’ marketed medicine Imcivree.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}